TRIM31 acts as an intermediate molecule in the process by which Snai2 impairs the proliferation of cervical cancer...

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Snai2 is a transcription factor known to inhibit cervical cancer cell proliferation and tumor growth.
• Wnt/β-catenin signaling pathway plays a crucial role in cervical cancer progression.
• The precise mechanism linking Snai2 and TRIM31 in cervical cancer remains elusive.

Purpose of the Study:

• To elucidate the regulatory mechanism of TRIM31 by Snai2 in cervical cancer.
• To investigate the role of the Snai2-TRIM31 axis in regulating the Wnt/β-catenin signaling pathway.
• To explore potential therapeutic strategies targeting Snai2, TRIM31, and the Wnt/β-catenin pathway.

Main Methods:

• RNA sequencing was performed on Snai2-overexpressing cervical cancer cells.
• Expression levels of Snai2, TRIM31, β-catenin, cyclin D1, and c-Myc were analyzed.
• Chromatin immunoprecipitation and luciferase reporter assays were used to confirm transcriptional regulation.

Main Results:

• Snai2 expression was inversely correlated with TRIM31 expression in cervical cancer cells.
• TRIM31 promotes cervical cancer cell proliferation and is upregulated in tumor tissues.
• Snai2 directly binds to the E-box in the TRIM31 promoter, transcriptionally inhibiting its expression.
• TRIM31 overexpression restored Wnt/β-catenin pathway activity in Snai2-overexpressing cells.

Conclusions:

• Snai2 inhibits cervical cancer cell proliferation and tumor growth by transcriptionally suppressing TRIM31.
• TRIM31 promotes cervical cancer progression via activation of the Wnt/β-catenin signaling pathway.
• The Snai2-TRIM31-Wnt/β-catenin axis represents a promising target for cervical cancer therapy.